CANF - Can-Fite Biopharma Ltd - ADR
IEX Last Trade
2.21
-0.040 -1.810%
Share volume: 117,415
Last Updated: Fri 30 Aug 2024 09:59:47 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$2.25
-0.04
-1.78%
Summary score
26%
Profitability
25%
Dept financing
12%
Liquidity
46%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-51.06%
Return on assets
-22.54%
Return on sales
0%
Return on invested capital
137.53%
Total debt ratio
53.04%
Debt ratio change over timeo
-0.2%
Current Ratio
4.58%
Quick Ratio
0%
Cash Position Ratio
3.09%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-94.48%
Return on assets
-36.27%
Return on sales
0%
Return on invested capital
203.65%
Total debt ratio
54%
Debt ratio change over timeo
-0.48%
Current Ratio
3.07%
Quick Ratio
0%
Cash Position Ratio
1.69%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-99.93%
Return on assets
-43.49%
Return on sales
0%
Return on invested capital
433.71%
Total debt ratio
48.53%
Debt ratio change over time
-0.38%
Current Ratio
3.45%
Quick Ratio
0%
Cash Position Ratio
2.33%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-193.62%
Return on assets
-137.23%
Return on sales
0%
Return on invested capital
102.66%
Total debt ratio
-19.54%
Debt ratio change over time
-0.2%
Current Ratio
5.09%
Quick Ratio
0%
Cash Position Ratio
2.93%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CANF | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -51.06% | -0.95% | 10.89% | 6.02% |
| Return on assets | -22.54% | 3.77% | 3.55% | 5.32% |
| Return on sales | 0% | 33.63% | 42.5% | 33.22% |
| Return on invested capital | 137.53% | 5.38% | 8.18% | 11.98% |
| Profitability | 25% | 38% | 68% | 61% |
| Total debt ratio | 53.04% | 101.27% | 72.64% | 29.07% |
| Debt ratio change over time | -0.2% | 4.69% | 5.62% | 1.56% |
| Dept financing | 13% | 46% | 43% | 14% |
| Current Ratio | 3.07% | 2.09% | 2.2% | 3.95% |
| Quick Ratio | 0% | 1.98% | 1.91% | 3.21% |
| Cash Position Ratio | 1.69% | 1.5% | 0.68% | 1.67% |
| Liquididy | 50% | 25% | 50% | 54% |
| Short-term ratios | CANF | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -94.48% | -26.47% | 18.76% | 5.16% |
| Return on assets | -36.27% | 4.51% | 3.92% | 4.18% |
| Return on sales | 0% | 37.94% | 39.67% | 29.9% |
| Return on invested capital | 203.65% | 9.05% | 8.77% | 11.34% |
| Profitability | 25% | 50% | 73% | 50% |
| Total debt ratio | 54% | 111.53% | 82.97% | 24.67% |
| Debt ratio change over time | -0.48% | -30.17% | 7.77% | 0.57% |
| Dept financing | 12% | 25% | 44% | 7% |
| Current Ratio | 3.07% | 2.09% | 2.2% | 3.95% |
| Quick Ratio | 0% | 1.98% | 1.91% | 3.21% |
| Cash Position Ratio | 1.69% | 1.5% | 0.68% | 1.67% |
| Liquididy | 44% | 51% | 39% | 75% |